XWELL, Inc. (NASDAQ:XWEL)
| Market Cap | $3.25M-43.8% |
| Revenue (ttm) | $28.28M-7.6% |
| Net Income | -$23.42M-21.1% |
| EPS | -$5.29-27.8% |
| Shares Out | 7.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,886 |
| Open | $0.44 |
| Previous Close | $0.44 |
| Day's Range | $0.40 - $0.50 |
| 52-Week Range | $0.26 - $2.20 |
| Beta | 0.94 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 23, 2026 |
About XWEL
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Next catalysts
- Nov 23, 2026Earnings report
$XWEL stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in XWEL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by XWEL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
XWEL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
XWEL Revenue by Segment or Geography
| Disaggregation of Revenue | $7.14M | 50.94% |
| Expected revenue under contract | $6.88M | 49.06% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New XWEL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to XWEL from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in XWEL
| VXFVanguard Extended Market ETF | $35.41K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from XWEL’s recent data — informational, not investment advice
